Click here for the full video discussing the use of COVID-19 vaccines to prevent COVID-19 infections in patients with inflammatory bowel disease.
Click here for the full video of Drs. Rubin, Siegel, Melmed, and Horrigan discussing the safety and efficacy of COVID-19 vaccines for patients with inflammatory bowel disease.
Dr. Rubin Discusses Advances in Anti-Cytokine Therapy: The Current and Potential Role of IL-12/23 and IL-23 Inhibitors in the Treatment of IBD
Click here to watch Dr. Rubin discuss the advances in anti-cytokine therapy and receive AANP, AAPA, CME, CNE, CPE, or participation credit.
Watch this video exclusive, to hear David T. Rubin, MD highlight how the COVID-19 pandemic changed the use of social media.
Click here to watch Dr. David Rubin and his colleagues explain the data behind the various vaccines, clinical recommendations, allergy and safety recommendation, and describe COVID-19 vaccine special issues in underrepresented minorities.
Click here to watch Dr. Rubin and Dr. Long review the role of cell trafficking in IBD pathogenesis and how therapies that modulate immune cell trafficking compare with other agents that target the inflammatory response in IBD.
Many people with Ulcerative Colitis wonder whether it’s possible to have a satisfying sex life. Dr. David Rubin discusses how to address the situation with your physician and partner. Read more here.
Dr. Rubin was recently announced as one of three recipients of the 2020 Sherman Prize. Sherman Prize recipients “are outstanding individuals who consider the whole patient experience — not just the serious symptoms, but also the psychological and practical components of IBD. Their work is innovative and impactful, and goes well beyond the norm, generating positive benefits on behalf of patients, their families and caregivers, and the future trajectory of the field. They are out-of-the-box thinkers who energize others to enter the fight to overcome Crohn’s and colitis.”